Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children

Steven Shea1, Eve Aymong, Patricia Zybert

  • 1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. ss35@columbia.edu

Obesity Research
|January 17, 2003
PubMed

Insights

Obesity in young children is linked to higher fasting insulin levels. Fasting insulin, in turn, is associated with increased C-reactive protein, a marker of inflammation.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Inflammation Markers

Background:

  • Obesity is linked to hyperinsulinemia and elevated C-reactive protein in older individuals.
  • Limited data exists on these associations in very young children.

Purpose of the Study:

  • To investigate the relationships between obesity, insulin levels, and C-reactive protein in healthy 2- to 3-year-old children.

Main Methods:

  • Analysis of data from 491 healthy Hispanic children aged 2-3 years.
  • Measurements included Body Mass Index (BMI), ponderal index, skinfolds, fasting insulin, glucose, and C-reactive protein.
  • Multivariate regression analyses were used to assess associations, adjusting for age and sex.

Main Results:

  • Obesity measures (BMI, ponderal index) strongly correlated with each other.
  • Fasting insulin level was the primary driver of insulin resistance index variability.
  • BMI and ponderal index were associated with higher fasting insulin levels (p < 0.001).
  • Fasting insulin level, not obesity measures, was associated with C-reactive protein level.

Conclusions:

  • Obesity is associated with elevated fasting insulin levels in healthy 2- to 3-year-old children.
  • Fasting insulin levels are positively associated with C-reactive protein levels in this age group.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...